ALEXANDRIA, Va., July 13 -- The United States Patent and Trademark Office (USPTO) published about the trademark 'KYMFABI' in its latest official gazette. The trademark application with the serial number 79254291 was filed on Feb. 1, 2019.
Here are the other related details:
Goods and Services: 5 - Pharmaceutical products for human use for the treatment of Fabry disease and symptoms and sequelae of Fabry disease, excluding products used in cell therapy or gene therapy or for treatment of blood diseases
International/US Class(es): 5
Mark Drawing Code: 4 - STANDARD CHARACTER MARK
Current Owner(s): Idorsia Pharmaceuticals Ltd Hegenheimermattweg 91 CH-4123 Allschwil CH SWITZERLAND 99 Limited
Disclaimer: Curated by HT Syndication....